8-K filing — CHAMPIONS ONCOLOGY, INC. (CSBR)
Filed: 2026-07-27 AccNo: 0001628280-26-049822 Size: 417 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Champions Oncology Expands Radiopharmaceutical Platform With In-House SPECT/CT Imaging For Integrated Tumor Biology And Efficacy Insights
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Champions Oncology Q4 Adj. EPS $0.01 Beats $(0.05) Estimate, Sales $13.835M Beat $12.886M Estimate
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.05) by 120 percent. This is a 114.29 percent increase over losses of $(0.07) per share